In This Section
Cancer Biology, PhD
Our multidisciplinary curriculum combines the basic mechanisms of cancer biology with the translational aspects of drug discovery. At USciences, you’ll receive hands-on training in our state-of-the-art laboratories from faculty at the cutting edge of research. Upon completion of the program, you’ll be prepared to advance the fight against cancer in an academic, governmental, or industrial career.
What Sets Us Apart?
- Our unique program features an integrated training experience with renowned researchers from both USciences and The Wistar Institute, an international leader in biomedical research with special expertise in cancer
and vaccine research.
- Tuition for accepted students in the Cancer Biology, PhD is fully funded by USciences and The Wistar Institute.
- With our experienced faculty and comprehensive curriculum, you'll acquire training
in emerging approaches to cancer prevention and therapy.
- Small class sizes and mentorship allow you to learn from and build valuable relationships with expert
- In the classroom, you will study the latest developments in the understanding of cancer,
therapeutic strategies, and therapeutic compounds.
- In the lab, you will work side-by-side with world-renowned faculty members, exploring
molecular signaling pathways, tumor targeting, and other aspects of drug discovery,
in the heart of the region's biotechnology and health sciences industries.
- Hands-on work in Wistar’s Molecular Screening & Protein Expression Facility provides
an introduction to high-throughput approaches in therapeutic discovery and development
of robust, well-validated bioassays.
- To date, program graduate have all published first-author papers in Nature, PNAS, Cancer Research, and other high-impact journals.
USciences Celebrates Its 198-Year History at Founders' Day
February 18, 2019
With pomp and circumstance, USciences faculty, staff, students, alumni, and friends marked 198 years since the University was established at a special Founders' Day ceremony on Feb. 14, 2019.
The Opportunity Journey: Innovative Program Prepares Next Generation Scientists
January 24, 2019
According to Brian Keith, Ph.D., Wistar dean of Biomedical Studies, basic cancer research unravels the complex cellular and genetic mechanisms that underlie disease, and spurs the development of new, rationally designed therapies to ultimately improve patient outcomes.
What Kind of Bacteria Are on the Bottom of Our Shoes?
July 10, 2018
Jason Heindl PhD, assistant professor of biology, helped to guide Jenn Frederick from Fox29's Good Day Philadelphia through the kind of bacteria cultivated from the morning show team members' shoes.
Mentorship in USciences' Lab Helps High School Student Advance Research
April 05, 2018
With the guidance of Dr. Heindl, Zhong was able to advance her hypothesis and explore how the bacteriophage viruses can communicate with each other.
Kenneth Myers, PhD
Associate Professor of Biological Sciences and Neuroscience
McNeil Science and Technology Center, Room 348
University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495
Brian Keith, PhD
Professor and Dean of Biomedical Studies
The Wistar Institute
3601 Spruce Street
Philadelphia, PA 19104